Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Heron Therapeutics
(NQ:
HRTX
)
2.930
-0.120 (-3.94%)
Streaming Delayed Price
Updated: 11:29 AM EST, Feb 8, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
402,356
Open
3.010
Bid (Size)
2.930 (25)
Ask (Size)
2.940 (13)
Prev. Close
3.050
Today's Range
2.879 - 3.020
52wk Range
2.190 - 9.450
Shares Outstanding
118,888,122
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
Top News
More News
Why Omeros Are Trading Higher By 32%? Here Are Other Stocks Moving In Monday's Mid-Day Session
February 06, 2023
Gainers Secoo Holding Limited (NASDAQ: SECO) jumped 156% to $4.3600. Arqit Quantum Inc. (NASDAQ: ARQQ) gained 41.5% to $3.54.
Via
Benzinga
Heron Therapeutics Files For Expanded Use Of Zynrelef In Soft Tissue, Orthopedic Surgical Procedures
December 29, 2022
Via
Benzinga
Performance
YTD
+20.57%
+20.57%
1 Month
+13.56%
+13.56%
3 Month
-15.08%
-15.08%
6 Month
-28.71%
-28.71%
1 Year
-67.04%
-67.04%
More News
Read More
7 Penny Stocks to Buy for 10-Bagger Returns
November 15, 2022
Via
InvestorPlace
Analysts Cut Price Targets As Heron Therapeutics' Zynrelef Disappoints In Q3
November 09, 2022
Via
Benzinga
FDA Approves Heron Therapeutics' Post-Op Nausea Treatment
September 19, 2022
Via
Benzinga
Heron Shares Jump After Equity Financing, Q2 Earnings
August 09, 2022
Via
Benzinga
Earnings Outlook For Heron Therapeutics
November 07, 2022
Via
Benzinga
Hurry! 7 Pitiful Stocks to Sell Before 2022 Ends
November 04, 2022
Via
InvestorPlace
12 Health Care Stocks Moving In Friday's After-Market Session
October 07, 2022
Via
Benzinga
4 No-Brainer Penny Stocks to Buy if You Have Money to Invest
September 26, 2022
Via
InvestorPlace
7 Unknown Biotech Stocks That Could Rocket in 2023
September 23, 2022
Via
InvestorPlace
Bluebird bio Seeks Back-to-Back Nods, 'Go' or 'No-Go' For Revance's Botox Rival, Amylyx' Twin Hurdles And More: September's Key PDUFA Catalysts Biotech Investors Must Know
August 31, 2022
Via
Benzinga
Why Verona Pharma Is Trading Higher By Around 84%, Here Are 85 Stocks Moving In Tuesday's Mid-Day Session
August 09, 2022
Via
Benzinga
Why Avalo Therapeutics Surged 32%; Here Are 111 Biggest Movers From Yesterday
August 10, 2022
Via
Benzinga
Earnings Outlook For Heron Therapeutics
August 08, 2022
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
July 26, 2022
Via
Benzinga
7 Biotech Stocks to Buy for Q3
July 18, 2022
Via
InvestorPlace
The Week Ahead In Biotech (May 8-14): Bausch Health Headlines Smid-Cap Earnings, Veru's Pre-EUA Meeting, Conference Presentations And More
May 09, 2022
Via
Benzinga
Stocks That Hit 52-Week Lows On Monday
June 06, 2022
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
March 01, 2022
Via
Benzinga
80 Biggest Movers From Yesterday
March 02, 2022
Via
Benzinga
44 Stocks Moving In Tuesday's Mid-Day Session
March 01, 2022
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
March 01, 2022
Via
Benzinga
The Daily Biotech Pulse: Legend Biotech, CTI Biopharma Receive FDA Approvals, AbbVie Announces Delay In Skyrizi Review, Editas Gains On CRISPR Patent Resolution
March 01, 2022
Via
Benzinga
Heron Therapeutics: Q4 Earnings Insights
February 28, 2022
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.